- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hitachi plans U.S. MRI laboratory
Citing continued strong sales, Hitachi Medical Systems Americahas announced plans to establish an MRI research and developmentlaboratory at its U.S. headquarters in Twinsburg, OH. The group will develop new technologies, advanced clinicalapplications,
Citing continued strong sales, Hitachi Medical Systems Americahas announced plans to establish an MRI research and developmentlaboratory at its U.S. headquarters in Twinsburg, OH.
The group will develop new technologies, advanced clinicalapplications, and hardware and software enhancements, accordingto Sheldon Schaffer, HMSA vice president of marketing. Researchwill involve superconducting and permanent magnet technologies.
The company will recruit five engineers to staff the new facility,which will complement Hitachi's existing R&D operations inJapan.
HMSA, a joint venture between Hitachi and Summit World Trade,sells Hitachi MRI systems in the U.S.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
